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Abstract.  Actin-binding protein (ABP-280,  nonmuscle 
filamin) is a ubiquitous dimeric actin cross-linking 
phosphoprotein of peripheral cytoplasm, where it pro- 
motes orthogonal branching of actin filaments and 
links actin filaments to membrane glycoproteins. The 
complete nucleotide sequence of human endothelial 
cell ABP cDNA predicts a polypeptide subunit chain 
of 2,647 amino acids, corresponding to 280 kD, also 
the mass derived from physical measurements of the 
native protein. The actin-binding domain is near the 
amino-terminus of the subunit where the amino acid 
sequence is similar to other actin filament binding 
proteins, including t~-actinin,/3-spectrin, dystrophin, 
and Dictyostelium abp-120.  The remaining 90%  of the 
sequence comprises 24 repeats, each ~96 residues 
long, predicted to have stretches of/3-sheet secondary 
structure interspersed with turns. The first 15 repeats 
may have substantial intrachain hydrophobic interac- 
tions and overlap in a staggered fashion to yield a 
backbone with mechanical resilience. Sequence inser- 
tions immediately before repeats 16 and 24 predict two 
hinges in the molecule near points where rotary- 
shadowed molecules appear to swivel in electron 
micrographs. Both putative hinge regions are suscepti- 
ble to cleavage by proteases and the second also con- 
tains the site that binds the platelet glycoprotein Ib/IX 
complex. Phosphorylation consensus sequences are 
also located in the hinges or near them. Degeneracy 
within every even-numbered repeat between 16 and 24 
and the insertion before repeat 24 may convert interac- 
tions within chains to interactions between chains to 
account for dimer formation within a domain of 7 kD 
at the carboxy-terminus. The structure of ABP dimers 
resembles a leaf spring. Interchain interactions hold 
the leaves firmly together at one end, whereas in- 
trachain hydrophobic bonds reinforce the arms of the 
spring where the leaves diverge, making it sufficiently 
stiff to promote high-angle branching of actin illa- 
ments. The large size of the leaves, their interruption 
by two hinges and flexible actin-binding site, facilitate 
cross-linking of widely dispersed actin filaments. 
N 
ONMUSCLE cells achieve a wide variety of shapes by 
arranging peripheral linear actin filaments in differ- 
ent ways. Actin-modulating proteins are responsible 
for this versatility by adjusting actin filament length and by 
defining the organization of actin filaments and their binding 
to other cellular components (54, 56). Actin-binding protein 
(ABE also called nonmuscle filamin) ~ was among the first 
such  proteins  discovered  (25, 55,  62)  and  has  a  broad 
phylogenetic distribution  (3, 4, 34, 47, 49, 51, 59, 60, 63). 
ABP from most cell types examined promotes high-angle 
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branching of actin filaments (24,  27, 40), an attribute  ini- 
tially inferred from its potency in initiating the gelation of 
actin  filament  solutions  (6,  26).  Smooth  muscle  ABP 
(filamin) from chicken gizzard, on the other hand, causes 
bundling of actin filaments despite extensive immunologic 
and hydrodynamic similarity with ABP from other cells (6, 
14, 45). 
Since rodlike linear polymers tend to align  in parallel 
when the local concentration is high, it is not surprising that 
most  actin-cross-linking  proteins  stabilize  actin  filament 
bundles.  However, ABP is remarkable in generating near 
perpendicular branching  of long  helical  actin  filaments. 
Previous analysis of ABP's structure gave some insights into 
how this is done. Hydrodynamic and electron microscopic 
analyses have showed ABP to be a homodimer (26),  with 
subunit size 270 kD and dimensions  of 3-5 nm width and 
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The Journal of Cell Biology, Volume 111, September 1990 1089-1105  1089 Figure  1.  (A)  Specificity of mouse monoclonal IgGs  1-4 for ABP 
and (B) demonstration that mAbs  1 and 2, but not 3 and 4, bind 
to the fusion protein encoded by ~gtll  clone 2.  (A) Rabbit lung 
macrophages were dissolved with 1%  SDS and polypeptides dis- 
played by SDS-PAGE, electrophoretically transferred to nitrocellu- 
lose  paper,  and  immunoblotted  against  each  mAb  followed  by 
peroxidase-conjugated  secondary  IgG.  Only  the high molecular 
weight subunit of ABP is recognized by each of the mAb (B) Au- 
toradiograph showing that only rnAbs 1 and 2 recognize the hgtl 1 
clone 2 fusion protein. Colonies were blotted on nitrocellulose pa- 
per, incubated with each monoclonal IgG  followed by  t25I-anti- 
mouse IgG. 
160 ran length (26, 58). Because subunits contain both self- 
association and actin-binding sites, the intact molecule can 
erosslink two  aetin  filaments.  Electron micrographs  sug- 
gested that subunit self-association involved an end-to-end 
attachment of the filamentous strands and actin binding oc- 
curred at the distal portion of  each free end of  the ABP mole- 
cule, which seemed to attach to the groove between the long- 
pitch strands of the actin helix. It was proposed that the large 
size of ABP and separation of its actin-binding sites were 
prerequisites for the orthogonal cross-linking of actin illa- 
ments. Recent rheologic studies of ABP/actin gels confirm 
that they resemble eovalently crosslinked networks and dis- 
play considerable elastic properties in contrast to gels made 
from actin alone (30). 
ABP also mediates the association of cytoskeletal actin 
with the plasma membrane protein GPIb/IX complex of hu- 
man blood platelets (20, 43) and with a glycoprotein in other 
cell-types. Therefore ABP molecules have a binding site for 
integral membrane glycoproteins, as well as self-association 
and actin filament binding domains. In addition, ABP is a 
phosphoprotein, whose extent of  phosphorylation changes in 
response to cell activation (8, 9, 59). 
This paper reports the complete primary sequence of ABP 
inferred from eDNA clones and the identification  of its func- 
tional domains by mapping of proteolytic fragments with 
mAbs and by functional analysis of genetically engineered 
fragments secreted by Cos ceils. The observations suggest 
how ABP can cause high-angle branching of actin filaments. 
Materials and Methods 
Mouse lgG mAbs against ABP 
Mouse mAb to rabbit macrophage,  and human platelet and uterus ABP 
were produced.  Balb/C mice were immunized every 3 wk with a total of 
four injections of 50 #g of ABE the first in CFA, the latter three in incom- 
plete Freund's  adjuvant (1 vol ABP in PBS/I  vol adjuvant).  A final boost 
of 20 ttg of ABP in PBS was injected into the tail vein 3 d before splenec- 
tomy. Homogenized  spleen cells were fused with P3-NS1-Ag4-1 myeloma 
cells with 30% polyethylene glycol (Mr 1,000). Hybridomas secreting anti- 
bodies specific  for ABP were  identified  by ELISA  assay of ABP coated 
wells. 96-well microtiter plates were coated with 50 ~tl of 5 ~tg/mi of actin- 
binding protein in 10 mM sodium bicarbonate buffer, pH 9.6 for 2 h. 50 
/~1 of culture medium was added to each well and incubated at room temper- 
ature for 2 h. The test solutions were removed and wells washed with PBS 
containing 0.2 % Tween. Bound IgG was identified with peroxidase-labeled 
goat anti-mouse IgG. Secreting  hybridoma cells were subcloned twice by 
limiting  dilution, and injected peritoneally into pristane-primed mice. Anti- 
bodies were purified from ascites fluid, obtained 7-10 d after injecting hy- 
bridoma cells,  by precipitation with 45%  ammonium sulfate  and ion ex- 
change chromatography on DEAE-Sepharose. 
Four IgG mAbs specific  for rabbit macrophage,  human uterine, and 
platelet ABP were prepared and designated mAbs 1-4. Fig.  1 shows an im- 
munobtot illustrating  the specificity of each antibody for rabbit macrophage 
ABE  Total  macrophage  proteins were  solubilized  in SDS,  polypoptides 
separated  by  electrophoresis  through 5-15% polyacrylamide  slab  gels, 
transferred to nitrocellulose  membrane and incubated with each mAb (57). 
In all cases,  IgGs bound only the high molecular weight subunit of ABE 
Identical  results  were obtained using extracts  of human uterus (data not 
shown). The binding location of each mAb was mapped on the ABP subunit 
in proteolytic  studies  (Fig. 4 c). 
Protein Purification, Proteolysis of  ABP, 
and Amino-Terminal Peptide Sequencing of  Proteolytic 
and Chemical Fragments 
ABP was purified from human uterus as previously described (26). Purified 
ABP was  proteolysed  with calpain and trypsin.  Calpains I and II were 
generous gifts from Dr. Dorothy Croall (Department of Physiology, Univer- 
sity of Texas Health Science Center) and Dr. Darell Goll (University of Ari- 
zona, Muscle Biology Group), respectively. 
Digestion with Calpain. Purified human uterus ABP in 0.1 MKCI, 0.5 
mM DTT, and 10 mM imidazole-HCl,  pH 7.5 was incubated with calpain 
at a weight ratio of I00 ABP:I calpain for 0-60 rain at room temperature. 
Proteolysis  was initiated by the addition of calcium to a final concentration 
of 2 mM and quenched with EGTA at a final concentration of 5 raM. The 
enzymatic digest was subjected  to 5-15% SDS-PAGE and transferred to 
Immobilon-P. 
Digestion with Trypsin. Human ABP in 0.1 M KCI,  10 mM imidazole- 
HCI, 0.1 mM EGTA, 1 mM DTI" pH 7.5, was digested with TPCK-trypsin 
(Sigma Chemical Co., St. Louis, MO) using a final molar ratio of 25 mol 
of ABP:I tool trypsin for 0-60 rain at room temperature.  The digestion was 
stopped at times of 0, 5, 15, 40, and 60 rain by adding soybean trypsin inhibi- 
tor (Sigma Chemical Co.) at equal weight to trypsin. The enzymatic digest 
was subjected to 5-15 % SDS-PAGE and transferred to Immobilon-P (Milli- 
pore Corp., Bedford,  MA) by Western blot. 
Protein Sequencing. Western blots from both tryptic and calpaln digests 
and cyanogen bromide-cleaved ABP were stained with Coomassie brilliant 
blue and the 100-kD band from the Calpain digest and selected bands from 
the tryptic digest and chemical cleavage were excised and sequenced (38). 
Binding of  ABP and its Proteolytic Subfragments 
to Actin 
An F-actin cosedimentation assay was used to determine which tryptic or 
calpain fragments bound actin filaments. Increasing concentrations  of intact 
human uterine ABP (control) or ABP digests  were  mixed and incubated 
with 100 td of 3 #M F-actin in 0.1 M KC1, 2 mM MgC12, 0.1 mM EGTA, 
0.5 mM/~-mercaptoethanol, 10 mM imidazole-HCl,  pH 7.5 for 30 rain at 
room temperature.  Samples  were centrifuged  at 200,000  g  for  15  rain 
(model TL-100 centrifuge;  Beckman Instruments, Fullerton, CA) at 4°C, 
separated into supernatants and pellets, solubilized in gel sample buffer, and 
electrophoresed  on 5-15 % polyacrylamide slab gels in the presence of 0.1% 
SDS. ABP in each sample was quantitated by densitometric scanning after 
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Figure 2.  Sequencing  strategy of human ABP and alignment of 
overlapping eDNA clones.  All clones were isolated from human 
endothelial cell Xgtll  libraries. The original isolate was clone 2. 
The location of important restriction enzyme sites is indicated. The 
diagram aligns the ABP eDNA with important functional domains 
of the ABP subunit. 
Coomassie brilliant blue staining.  Subfragments  of ABP retaining F-actin 
binding activity (sedimented with F-actin) were aligned relative to the intact 
subunit by immunoblotting with the panel of anti-ABP mAbs. 
EM of  Human Uterus ABP 
ABP at a concentration of 50/~g/ml in 50% glycerol containing 0.1 M KC1, 
0.1  mM EGTA,  0.1  mM DTT, and 10 mM imidazole-HCl,  pH 7.5 was 
sprayed onto freshly cleaved mica (58),  vacuum dried, and rotary coated 
with tantalum-tungsten  at 5 ° and carbon at 90  ° in a freeze-fracture  machine 
(model  CFE-50; Cressington, Watford,  England). Replicas  were floated 
from the mica in 50% hydrofluoric  acid, washed in water, and picked up 
on copper grids. 
cDNA Cloning 
Escherichia coli expressing/3-galactosidase-ABP  fusion proteins directed 
by infection with human umbilical vein endothelial cell (HUVEC) eDNA 
libraries in hgtl 1 (both oligo dT and randomly primed eDNA libraries were 
generously provided by Dr. Stuart Orkin) (22) were initially identified using 
a  mixture of anti-ABP mAbs  1 and 2 and t25I-labeled secondary rabbit 
anti-mouse IgGs. Clone 2, the original isolate,  was subsequently  shown to 
be recognized by each of the individual mAbs 1 and 2 (Fig.  1). Its eDNA 
insert was isolated from the recombinant phage by standard methods (36), 
subcloned into M13  (39),  and sequenced using the dideoxy  method of 
Sanger (48).  Where restriction sites were lacking,  serial deletions were 
created in the cDNA subcloned into plasmid vectors pUC13 (Bethesda Re- 
search Laboratories, Gaithersburg, MD) and Bluescript SK+ (Stratagene 
Corp., La Jolla, CA) using the Exonuclease  III method of Henikoff (28). 
The resultant deleted plasmids were sequenced after subcloning into M13, 
or directly sequenced using synthetic oligonucleotide  primers derived from 
either vector or ABP sequence.  The libraries were rescreened with probes 
from either end of clone 2. Through a series of rescreenings, seven overlap- 
ping clones spanning 8.4 kb were isolated and sequenced in both directions 
(Fig. 2). More than 300 bp of identical overlapping sequence in both direc- 
tions was used to document that each new clone represented a contiguous 
cDNA sequence.  Clone  1 in Fig.  2 was subcloned from ),gtll using the 
polymerase chain reaction (PCR).  A  toothpick was applied to plaques, 
added to a standard PCR mix (16), and heated 5 rain at 95°C to destroy 
DNases.  30 cycles of amplification were performed using an antisense oli- 
gonucleotide and a hgtll forward  or reverse primer.  To ensure sequence 
fidelity during amplification,  four separate clones were sequenced. 
Northern Analysis 
Total cellular RNA derived from human white blood cells, uterus, a hepa- 
toma (G2) cell line, and rabbit alveolar macrophages was prepared by the 
guanidium thiocyanate  method (10). Fresh tissue was combined with 4 M 
guanidium thiocyanate, homogenized, and layered onto a 5.7 M CsC1 cush- 
ion and centrifuged at 35,000 rpm (115,000 g) for 8 h. The pelleted RNA 
was  ethanol washed,  resuspended,  ethanol precipitated,  and quantitated 
spectrophotometricaUy  after resuspension in a Tris EDTA buffer. 10 #g to- 
tal cellular RNA (per lane) was electrophoresed through a denaturing 2.2 M 
formaldehyde,  1% agarose gel, and transferred via capillary blotting to a 
synthetic support (Genescreen; New England Nuclear,  Boston, MA). The 
transferred RNA was analyzed by hybridization with probes prepared from 
the various  ABP eDNA clones. 
Cos Cell Expression of  ABP Truncates 
eDNA encoding regions within ABP's carboxyl- and amino-ends were sub- 
cloned into the CDM8 plasmid (50). This Cos cell expression vector yields 
high  transient  expression  of  transfected  protein  constructs.  The  self- 
association domain of ABP was mapped to the carboxy-terminal  repeat by 
creating two hybrid constructs including  repeat motifs 21-24 (henceforth 
named 21E-24H =  residues 2,282-2,647) or repeat motifs 21-24 with the 
last 65 residues deleted (21E-24C = residues 2,282-2,582), subcloned into 
the CDM8-PLGE plasmid. The former construct included the native ABP 
stop codon whereas the latter construct was formed by ligating the Pst I site 
(base •7,993)  to the Pst I site in the CDM8 polylinker region that encodes 
a hexapeptide  RSRPRL  before an in-frame stop codon. Each transfected 
construct encoded a  fusion protein incorporating the amino-terminal 40 
amino acids of plasma gelsolin including its signal peptide (that is cleaved 
off during the secretion process) and 12 residues unique to its plasma exten- 
sion (relative  to cytoplasmic gelsolin).  The proteins produced are both 
secreted into the media and identifiable using a rabbit antibody generated 
against a synthetic peptide composed of the first 15 residues of plasma gelso- 
lin. A eDNA construct encoding ABP residues 183-689 was similarly fused 
to  the  plasma  gelsolin eDNA  (again  encoding  the  amino-terminal 40 
residues)  after  addition  of  synthetic  oligonucleotide  "three-frame stop 
codon" linkers to the 3' terminus of the partial ABP eDNA and subcloned 
into the CDM8 plasmid. Hybrid constructs were transfected into Cos cells 
using dextran followed by DMSO shock.  The cells were allowed to grow 
for 16-24 h in 10% serum-containing media then washed in HBSS (Gibco 
Laboratories, Grand Island, NY) and grown for 48 h in serum-free media. 
The sernm-free media was collected over a 48-h span, dialyzed in 1,000 vol- 
ume of 10 mM Tris, pH 7.4, containing 1 mM DTT and 5 mM EGTA and 
freeze-dried. 
Chemical Cross-linking of the Expressed 
ABP Truncates 
The freeze-dried  Cos cell media containing the expressed  proteins were 
resuspended  in 0.15 ml of 0.5 M KCI, 200 mM triethanolamine  pH 8.5 and 
1%/~-mercaptoethanol,  dialyzed against the same and clarified by centrifu- 
gation in an ultracentrifuge (TL-100;  Beckman Instruments) at 106,000 g 
for 15 min at 4°C.  Aliquots were removed for SDS-PAGE (uncross-linked 
control) and dimethyl adipimate (DMA) dissolved in the triethanolamine 
buffer was added at concentrations of 2.5 and 5 mg/ml.  Samples  were in- 
cuhated with crosslinker for 2 h at 37°C. The reaction was stopped by boil- 
ing in SDS containing sample buffer and electrophoresed through 5-15% 
polyacrylamide  slab gels in the presence of 0.1% SDS. Polypeptides  were 
electrophoretically  transferred to Immobilon-P, nonspecific protein binding 
sites blocked with 5 % nonfat dry milk (Carnation, Los Angeles,  CA) and 
ABP truncates identified  using anti-amino-terminal plasma gelsolin IgG 
and anti-ABP mAb IgGs and peroxidase-labeled  secondary antibodies. 
Computer~Fourier  Analysis of the Sequence 
The nucleotide and protein sequence of ABP was analyzed using programs 
available  to users of Bionet/Inteiligenetics,  the University of Wisconsin 
Genetic Computer Group (UWGCG) Programs and by Fourier analysis to 
detect regularly  repeating  motifs  (53).  Manipulations of the primary se- 
quence were performed using SEQED and comparisons with COMPARE 
and DOTPLOT  programs (UWGCG; [35]).  Secondary  structure predic- 
tions were analyzed according to the method of Chou-Fasman (12) and Rob- 
son and Suzuki (44); via the programs PEPTIDESTRUCTURE and PLOT- 
STRUCTURE (UWGCG). Database searches included those available via 
UWGCG.  Comparison of the amino terminus of ABP with other actin- 
binding proteins and alignment of the 24 repeats used iterative applications 
of the GAP, LINEUP and PRETTY programs on LrWGCG. Fourier trans- 
forms were calculated (41) scoring secondary structure according to Robson 
and Suzuki  (44). 
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Figure 3.  Nucleotide and predicted  amino acid sequence of human ABP.  The three double underlined  regions  indicate  the sequence of 
amino acids  obtained  from the amino-terminal  sequencing of peptides  derived  from ABP by proteolysis with trypsin  (peptide  residues 
2,33"/-2,347), cyanogen bromide cleavage (peptide residues 29%303) or calpain cleavage (peptide residues  1,'/62-1,764).  The calpain site 
was determined  by sequencing  the amino terminus of the 100-kD fragment (see Figs.  4 c and 5). Two potential kinase substrate regions 
are underlined with scalloped lines.  They are consensus phosphorylation  sites for cAMP kinase (residues  2,14%2,152) and Ca~÷/calmod  - 
ulin kinase (residues  2,520-2,523)  (2).  The potential  methionine initiation  codons are noted with arrows.  The first is considered  to be 
the native initiation site, as discussed in the text. These sequence data are available from EMBL/GenBank/DDBJ under accession number 
53416. 
Results 
Cloning and the Primary Structure of Human ABP 
We used ABP monoclonal antibodies  to isolate a  series  of 
overlapping Xgtl 1 clones that span 8.4 kb of eDNA (Fig.  2) 
of which  7.94  kb  corresponded  to  a  single  open  reading 
frame encoding a 280-kD protein•  Several criteria confirm 
that  these  clones  encode  ABP.  First,  direct  sequencing  of 
three proteolyticaUy derived ABP peptides yielded sequences 
predicted from translation of the 7.94-kb open reading frame 
(double underlined  in Fig.  3).  Second,  ABP eDNA clones 
identified a single high molecular weight band in Northern 
blots of human RNA.  This band migrated more slowly than 
281 ribosomal RNA and was consistent with the •8-kb  size 
required  to  encode  ABP  (data  not  shown)•  Third,  eDNA 
clone 2 (Fig• 2), when expressed in E. coli as a/~-galactosidase 
fusion protein, was recognized by two distinct anti-ABP mAbs 
(1 and 2) and a polyclonal antibody (Fig.  1). Moreover, a fu- 
sion protein including ABP residues  183-689  expressed in 
Cos cells was recognized by mAb 4.  Finally,  the predicted 
amino acid composition of the translated  ABP sequence closely 
matched  amino  acid  analysis  of ABP  and  filamin  from  a 
range of sources  (Table I)  (51,  55,  61). 
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Endothelial Cell ABP Compared with Amino Acid 
Composition of  Rabbit Macrophage ABP and Chicken 
Gizzard Filamin 
Chicken gizzard 
Amino acid  Human ABP  Rabbit ABP*  filamin$ 
tool 
ALA  7.2  7.4  9.3 
CYS  1.8  0.5  2.0 
ASP/ASN  8.4  8.7  7.6 
GLU/GLN  9.6  11.4  9.5 
PHE  2.9  3.2  2.9 
GLY  11.4  11.8  12.5 
HIS  2.5  2.1  2.3 
ILE  4.2  4.4  3.3 
LYS  6.0  6.0  4.8 
LEU  5.3  6.2  6.0 
MET  1.1  1.3  0.8 
PRO  7.9  7.1  8.0 
ARG  3.5  4.1  5.5 
SER  7.0  6.8  6.8 
THR  6.6  6.2  5.3 
VAL  10.5  8.5  10.0 
TRP  0.6  1.1  1.0 
TYR  3.2  3.1  2.6 
* Stossel and Hartwig (1976); • Wang (1977). 
Because the ABP amino terminus is blocked, we could not 
use direct amino acid sequencing to confirm the location of 
the initiation methionine. However, two considerations indi- 
cate that the position chosen in Fig. 3 is correct. First, 60-70 
bases upstream of the proposed initiation codon are  stop 
codons in all three frames. The methionine at residue 28 is 
also a potential initiation site,  although the presence of an- 
other in-frame ATG upstream from a documented initiation 
site,  without interposing termination codons,  is  unusual. 
Second, the predicted amino acid sequence at the proposed 
amino-terminus of ABP is similar to that found at the amino- 
terminus of ex-actinin (1,  66),  a Dictyostelium actin cross- 
linking protein (41) designated abp-120  by Condeelis (13), 
dystrophin (23),  and the/3-chain of nonerythroid spectrin 
(7).  Neither initiation sequence is flanked by the initiation 
consensus sequence (CCA/GCCAUGG) (32). Therefore, as- 
signment of the true initiation codon between methionine 1 
or 28 is tentative until more definitive evidence can be ob- 
tained. 
Molecular Organization of  ABP 
High-resolution electron  micrographs  of ABP  molecules 
(Fig. 4 b) show that they are constructed from two elongated 
chains that dimerize at one end, which we call the tail and 
which we now know corresponds to the carboxy-terminus of 
each chain. Accordingly, an ABP monomer can be divided 
into three principal domains: an actin-binding head, an elon- 
gated rod-like backbone, and a tail containing the dimeriza- 
tion site (Fig. 4 a). In the following sections, we will detail 
how many of these properties can be accounted for in terms 
of the primary structure of ABP. We show that the head has 
a primary structure related to the amino-terminal domains 
of several  other actin-binding proteins, whereas the back- 
bone or rod domain contains 24 tandem repeats, containing 
on average 96 amino acids, which account for the extended 
molecular structure of ABP. Moreover, systematic variations 
in the internal structure of these 96-residue repeats suggest 
a mechanism for chain dimerization and also a model, based 
on a  leaf spring,  that accounts  for  several  properties  of 
ABP-actin networks. 
Location of  ABP Functional Domains 
The location of the different functional domains of ABP in 
the amino  acid sequence was defined by using anti-ABP 
mAbs to map a range of proteolytic fragments and portions 
of ABP expressed in Cos cells. Once these fragments had 
been mapped, specific functions, such as actin-binding and 
dimerization, could be assessed and so assigned to defined 
regions of the sequence. Fig. 4 c summarizes the mapping 
data for ABP. 
As shown previously (18, 21, 64), proteolysis of ABP with 
calpain yielded fragments of 190, 100, and 90 kD (Fig. 5 a). 
Amino acid sequencing of the amino-terminal of the 100 kD 
fragment (TYA) located this calpain site between residues 
1,761 and 1,762, therefore the 190 and 100 kD fragments de- 
rived from the amino- and carboxy-termini of the chain, 
respectively, mAbs 1 and 2 bound to both the 100- and 90- 
kD calpain fragments (showing that the 90-kD fragment de- 
rived from the 100-kD  fragment), whereas mAbs 3 and 4 
bound the 190-kD  fragment (Fig. 5 b). Proteolysis of ABP 
with trypsin gave a more complex pattern of fragments, al- 
though two general patterns emerged. The initial cleavage 
resembled that with calpain and produced large (150-170 
kD) and small (90-100 kD) fragments (Fig. 6 a). More ex- 
tended proteolysis resulted in a  series  of polypeptides of 
sizes that were roughly multiples of 10 kD (Fig. 6 a), which 
indicated the  presence  of repeated  cleavage  sites  spaced 
~100 residues apart. As shown in Figs. 5 and 6, the 190-kD 
calpain fragment and the 170- and 90-kD tryptic fragments 
were all recognized by mAbs 3 and 4. The location of the 
mAb 4  epitope was defined more precisely by expressing 
cDNA corresponding to residues 183-689 of ABP as a hy- 
brid protein in Cos cells. The expressed protein was recog- 
nized by mAb 4, but not mAb 3, and did not cosediment with 
F-actin (data not shown). Therefore, the epitope for mAb 4 
was located between 20 and 75 kD from the ABP amino ter- 
minus, mAb 3 recognized 90- and 70-kD tryptic fragments, 
of which only the first bound actin. These data indicated that 
the epitope for mAb 3 was probably located towards the car- 
boxy-terminus of the 90-kD calpain and tryptic fragments. 
The Head Domain Binds F-Actin and Shares 
Homology with the Amino-Terminal Domains of 
Several Other Actin-binding Proteins 
The actin-binding properties of fragments of ABP localized 
the actin-binding site to near the amino terminus of the se- 
quence.  Fig.  7  compares the F-actin binding affinity and 
stoichiometry of intact ABP with calpain fragments using an 
actin cosedimentation assay. Both intact ABP and the 190- 
kD fragment pelleted with F-actin, whereas the 100- and 90- 
kD fragments remained soluble. ABP bound to F-actin with 
a  Kapp of 1 #M and capacity of 1 per  13.5 actin monomer 
subunits, consistent with previously published binding data 
(26).  The affinity of the 190-kD  fragment was diminished 
about threefold (calculated as a dimer for direct comparison 
The Journal of Cell Biology, Volume 111, 1990  1094 Figure 4.  (A) Schematic model of the predicted dimeric structure of the ABP molecule. Each monomer chain contains three domains: 
head, backbone, and tail. Each head contains an actin filament binding site within 274  residues of the amino-terminus. The backbone 
contains repeat blocks of 96 amino acids composed of the last half of each sequence repeat and the beginning of the following sequence 
repeat (see Discussion and Figs. 9 and 10 for derivation of this functional repeat). Repeats associate through hydrophobic intrachain bonding 
until repeat 16 which is preceded by a 25-residue insertion that contains a calpain cleavage site. This region may act as a flexible hinge 
allowing movement of ABP's heads to accommodate actin-binding. Intrarepeat bonding continues in motifs 16-23 and completes the back- 
bone of the subunit. The tail region (motif 24) is offset by a large -,35 amino acid insertion and the repeat abruptly terminates before 
the end of a functional repeat, thereby disrupting further intrachain bonding. The unpaired hydrophobic surfaces of motif 24 from two 
ABP subunits therefore are free to self-associate. Alternative models for ABP's structural repeat are described in the text. (B) Human 
uterus ABP molecules after glycerol spraying, vacuum drying, and metal coating with tantalum-tungsten at 5 °. Note the minimal region 
of monomer overlap. Bar, 0.1 #m. (C) Summary of studies aligning ABP's functional domains within its primary sequence. The approximate 
binding location of mAbs 1--4 (schematically drawn as Ys with numbers), important proteolytic fragments, and regions that have been 
expressed in bacteria and Cos cells are shown. These data are presented in detail in Figs. 5-7.  Calpain cleaves ABP into three pieces. 
The 187-kD fragment (190 kD by SDS-PAGE) contains the actin-binding site and ABP's amino terminus. A smaller 90-kD fragment can 
be made with trypsin that also contains ABP's amino terminus and binds actin. Smaller fragments of ABP with actin-binding activity have 
not been identified. 
Figure 5. Evidence that ABP's amino 
terminus corresponds to its free mo- 
lecular ends and contains the actin- 
binding site. Human uterus ABP, in 
0.1  M  KC1, 0.5  mM  DTT,  1  mM 
CaC12, and  10 mM imidazole-HC1, 
pH 7.5, was digested with calpain at 
a  molar ratio of 1 calpain:25 ABP 
molecules. Cleavage was terminated 
by the addition of EGTA to a  final 
concentration of 2  mM at the indi- 
cated times. The 270-kD ABP poly- 
peptide is rapidly cleaved by smooth 
muscle calpain into 190- and 100-kD 
subfragments. With longer digestion, 
a 10-kD piece is subsequently cleaved 
from the end of the 100 kD subfrag- 
merit. The 90-kD subfragment formed 
by this second cleavage, as well as the 
190-kD piece, are resistant to further 
calpain  cleavage. The sequence at the 
190/100-kD junction (TYA) determined by direct protein sequencing is located at residues 1,762-1,764  in the translated ABP sequence. 
The 100-kD fragment, therefore, includes ABP's carboxy terminus, and the 190-kD fragment, its amino terminus. (B) Autoradiographs 
demonstrating that mAbs 1 and 2 and 3 and 4 recognize different ends of the ABP subunit. Fragments from a 30-min calpain digestion 
were transferred to Immobilon paper and blotted against each anti-ABP mAb 1-4 followed by 125I-anti-mouse IgG. mAbs 1 and 2 recog- 
nize the carboxy-terminal 90-kD subfragment and mAbs 3 and 4  bind to the  190-kD amino-terminal subfragment. 
Gorlin et al. The Primary Structure of Human ABP  1095 with ABP), but its capacity changed slightly from 13.5-16 
actin monomers (also on a  dimer basis, which would cor- 
respond  to  8  actin  monomers per  fragment).  The  90-kD 
tryptic fragment, which bound mAb 4, also sedimented with 
F-actin (Fig.  6  c).  Combining the actin-binding activity of 
the proteolytic fragments with their mapping by monoclonal 
antibodies, the actin-binding site was localized to the amino- 
terminal third of each ABP monomer (Fig.  4  c). 
As illustrated in Fig. 8, there was substantial similarity be- 
tween the amino-terminal 275  residues of ABP and corre- 
sponding  residues  in  several  other  actin-binding  proteins 
such as c~-actinin  (1, 66), the ~-chain of nonerythroid spec- 
trin (7), and Dictyostelium abp-120 protein (41).  It is likely, 
therefore, that a similar function is located at ABP's amino 
terminus.  The greatest degree of homology between the se- 
quences was found at positions 44-54,  67-74, 99-150,  and 
235-265  in the ABP sequence. 
The Rod-like Backbone of  ABP Contains Multiple 
Tandem Repeats 
Dot matrix analysis of the ABP amino acid sequence (Fig. 
9 a) indicated that there were 24 tandem repeats of a motif 
with an average length of ,'~96 residues. This repeating pat- 
tern began at residue 276 and continued to the carboxy ter- 
minus.  Fig.  9  b  shows  an  optimized  alignment  of these 
repeating motifs. 
Interruptions in the Pattern of Tandem Repeats 
Indicate Flexible "Hinge" Regions in the ABP 
Rod Domain 
The regular pattern of tandem repeats in the rod domain was 
interrupted  in  five  places.  These  interruptions  produced 
characteristic horizontal and vertical gaps in the dot-matrix 
plot (Fig. 9 a) and were apparent when the repeating motifs 
were aligned  (Fig.  9  b).  Insertions of 20-40  residues  im- 
mediately before repeat motifs 16 and 24, and a 9-residue de- 
letion at the amino terminus of repeat 18 account for three 
of the gaps. The insertion before repeat 16 contains the site 
of initial calpain proteolysis (see Figs. 3 and 5). The amino 
acid sequence of the initial portions of repeats 20 and 22 also 
show deviation from the consensus  repeat, contributing to 
the apparent gaps on the dot-matrix analysis. 
Figure 6. Fragmentation of  human ABP with trypsin and identifica- 
tion of fragments that bind F-actin. (A) Time course for the cleavage 
of ABP by trypsin.  ABP was digested with trypsin at a molar ratio 
of 25 ABP:I trypsin at 4°C. Cleavage was stopped by addition of 
soybean trypsin  inhibitor  at the times indicated and the resulting 
polypeptides displayed by SDS-PAGE and stained with Coomassie 
brilliant blue. The ABP subunit is attacked by trypsin in a stepwise 
fashion, i.e., polypeptides decrease by 10-kD steps consistent with 
the length of the ABP repeat motif.  Molecular  weight standards 
(Biorad Laboratories, Richmond, CA) from top to bottom are: HMW 
=  200,  116, 97, 66, and 42 kD; ~  97, 66, 42,  31, 21, and 14 
kD. (B) Binding of trypsin cleavage fragments to F-actin demon- 
strating that fragments with sizes '~170 and 90 kD, that derive from 
the amino terminus, bind actin. Digests prepared as in A were mixed 
with F-actin,  and F-actin was collected by pelleting at 200,000 g 
for 15 min in a centrifuge (TL-100). Soluble and pelleted material 
were subjected to SDS-PAGE followed by Coomassie brilliant blue 
staining or (C) electrophoretically transferred to Immobilon paper 
and immunoblotted against mAbs 1-4 followed by ~25I-anti-mouse 
IgG.  The immunoblots  (autoradiographs)  demonstrate  that  only 
mAbs 3 and 4 recognize  170- and 90-kD  fragments from ABP's 
amino terminus that bind F-actin. The 90 kD fragment derives, there- 
fore, from fragmentation of the larger 170-kD fragment and an ac- 
tin binding site must be within ~<90 kD of ABP's amino terminus. 
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cleavage  fragments  of  ABP  to 
F-actin. As shown in Fig. 5, cal- 
pain cleaves ABP into fragments 
of 190 and 100/90 kD. We deter- 
mined which  cleavage fragment 
binds actin and compared its bind- 
ing activity to native protein. Hu- 
man uterine ABP in 0.1  M  KCI 
solution  of Fig.  5  was  cleaved 
with  calpain  and  actin  co-sedi- 
mentation assays were performed 
as  described  in  Materials  and 
Methods.  (A)  Binding  of  ABP 
mixed with ealpain in the pres- 
ence of I mM EGTA. The SDS- 
PAGE  shows  supernatants  (1-6) 
and  pellets (7-12)  of increasing 
concentrations of ABP incubated 
and cosedimented with 1 #M rab- 
bit skeletal muscle F-actin. The 
concentrations of ABP incubated 
with actin were 180 (lanes 1 and 
7), 120 (lanes 2 and 8), 60 (lanes 
3 and 9), 30 (lanes 4and 10), and 
15 (lanes 5 and 11) nM. Lanes 6 
and 12 show actin without added 
ABP. ABP in the absence of actin 
(lanes 13-18)  did not sediment. 
Concentrations of ABP in control 
lanes are 180 (lanes 13 and 16), 
120 (lanes 14and 17), and 60 nM 
(lanes 15 and 18). (B) SDS-PAGE 
showing  that  only  the  190-kD 
subfragment binds  F-actin.  The 
supernatants  (1-6)  and  pellets 
(7-12)  after  a  calpain digestion 
and  actin  cosedimentation  are 
shown.  The  concentrations  of 
ABP digested and mixed with ac- 
tin were 180 (lanes 1 and 7), 120 
(lanes 2 and 8), 60 (lanes 3 and 
9), 30 (lanes 4 and 10), 15 (lanes 
5  and//),  and 7.5  nM  (lanes 6 
and  12).  Calpain cleavage frag- 
ments do not sediment in the ab- 
sence of  added actin (control lanes 
13-18).  Concentrations  of ABP 
are  identical  to  corresponding 
lanes  in  A.  (C)  Scatchard  plot 
comparing the binding affinities 
and capacities of the 190-kD poly- 
peptide and native ABP to F-ac- 
tin. The content of 190-kD in the 
supernatant and actin pellet were 
determined by densitometric scan- 
ning of Coomassie brilliant blue- 
stained  SDS-PAGE.  ABP  binds 
to actin filaments with a  Kapp of 
1 #M and a capacity of 13.5 actin 
(monomer) subunits in a filament. 
After cleavage with calpain, both 
intact ABP and the  190-kD cal- 
pain-fragment pellet with  F-ac- 
tin, while the 100/90-kD subfragrnents remain soluble. The binding affinity of the 190-kD fragment for actin, relative to intact protein, 
is diminished about threefold. By Scatchard analysis, each  190-kD proteolytic fragment had a capacity of about eight actin monomers 
in filaments. 
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Figure 8. Comparison of ABP's ("ABP-280") amino-terminal 275-amino acid residues to that of Dictyostelium  abp-120, Drosophila [3-spec- 
trin, human c~-actinin, and human dystrophin.  Residues that are identical for all five sequences are enclosed by unshaded boxes. Shaded 
amino acids are either identical for three or four of the five sequences, or represent conserved substitutions falling into one of the following 
permutation matrix groups (PIR): D, E, N, Q; F, W, Y; A, G, S, T, H, K, R. Residue numbers correspond to the position of residues within 
the alignment matrix. Residues beyond 275 of ABP show no significant similarity to/~-spectrin,  ~actinin or dystrophin. These sequence 
data are available from EMBL/GenBank/DDBJ  under accession number 53416. 
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Secondary Structure Prediction for the 96-Residue 
Repeating Motif 
The  amino  acid  sequence  of the  rod  domain and  its  96- 
residue repeating motif were analyzed using a series of com- 
puter methods that make predictions  for secondary struc- 
ture.  Generally similar predictions were obtained with all 
methods, indicating that the features addressed were proba- 
bly genuine characteristics of the ABP sequence rather than 
properties peculiar to the prediction algorithm used. Within 
each motif was a  pattern of seven or eight short spans of 
residues with a high potential for B- or extended structure, 
separated by clusters of four or five residues such as glycine, 
proline, and asparagine that have a high probability of being 
located within turns.  Fourier analysis (Fig.  10)  confirmed 
the presence of the 96-residue repeat and indicated a degree 
of internal regularity within it. Thus, the Fourier transform 
of the B-potential along the rod sequence (Fig.  10 a) showed 
very strong peaks of intensity at frequencies corresponding 
to the eighth and ninth orders of the fundamental 96-residue 
repeat. As discussed previously (41), the appearance of such 
strong intensity at higher orders of the repeat indicates that 
the internal pattern of B-potential within each 96-residue mo- 
tif has a regular substructure, with units spaced ,,o12 residues 
apart. This can be seen in filtered traces of B-potential (Fig. 
10 b), which were produced using computer methods analo- 
gous to  those used  to  enhance the  structural  information 
present in electron micrographs of regular biological objects 
(see reference 52 for a review). In these filtered traces there 
were a  series of 8 maxima (96/12) each separated by ,,o12 
residues. 
A similar pattern was detected for turn potential, although 
the pattern of turn potential within a subunit was out of phase 
with that for B-structure,  so that when turn potential was 
high,  ~potential was low and vice versa. As illustrated in 
Fig. 9 b, this pattern correlated directly with the sequence, 
where eight zones, labeled A through H, could be identified. 
Each zone contained a series of residues of high B-potential 
(such as phenylalanine, leucine, isoleucine, valine and tyro- 
sine) followed by a series of turn predictors. The pattern was 
most marked in zones D through H, whereas zone B had the 
most variable sequence  and  weakest correlation  with  the 
predicted pattern of secondary structure.  This variation in 
the strength of the pattern between zones was also reflected 
in the filtered traces, where the pattern of B-potentiai alter- 
nating with turns was strongest for zones D-H (see Fig.  10 
b). Within the predicted runs of B-structure there was fre- 
quently a pattern of alternating hydrophobic and hydrophilic 
amino acid side chains,  similar to that observed with D/c- 
tyostelium abp-120 (41). This pattern was particularly strongly 
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ing aqua (hydrophilic) and magenta (hydrophobic) residues. 
In this figure, turn residues are represented in green.  The 
greatest degree of conformity to the consensus repeat was 
found within repeats 1-15 and repeats 17, 19, 21, and 23. The 
amino-terminal portions of repeats 16, 18, 20, 22, and 24 (as 
aligned in Fig. 9 b) showed the greatest divergence from the 
consensus.  The predominance of predicted/3-secondary struc- 
ture in the repeating motifs of the ABP rod was consistent 
with the 50-70%  content of/3-secondary structure and ab- 
sence of  a-helical structure observed by both circular dichro- 
ism and infrared spectroscopy for purified chicken gizzard 
smooth muscle filamin (31). 
Self-Association of  ABP Involves a Region within the 
Most Carboxy-Termina196-Residue Repeat Motif 
EM (26) has shown that the self-association of ABP mono- 
mers occurs at the opposite end to where the monomer binds 
actin. Because the actin-binding domain is located near the 
amino terminus, the dimerization domain (or "tail") must re- 
side near the carboxy terminus. This hypothesis is consistent 
with previously published data that showed that the 100-kD 
calpain fragment (which mAb mapping showed derived from 
the carboxy-terminal region of  the sequence) could be chem- 
ically crosslinked to form dimers (64). To define the region 
required for self-association, we expressed two carboxy-ter- 
minal constructs as secreted fusion proteins in Cos cells. Both 
constructs began at residue 2,281 in the middle of repeat 21 
(zone E in Fig. 9 b). The former construct included the natu- 
ral carboxy terminus (21E-24H).  The latter construct had 
the carboxy-terminal 65 residues deleted (by cleavage at the 
PstI site, Fig. 11 a), which removed the zones with strongest 
predicted B-sheet structure (21E-24C). Expression was me- 
diated by the CMD8 plasmid that initiated transcription  within 
the 5' portion of plasma gelsolin cDNA (encoding the exten- 
sion peptide required for secretion and plasma extension of 
gelsolin [33]) ligated to ABP cDNA encoding the carboxy- 
terminal residues of ABP. Chemical cross-linking with DMA 
(which cross-links native ABP effectively (61, 64) (Fig.  11 
b) showed that only the construct including the complete car- 
boxy terminus (21E-24H), but not the construct missing the 
last 65 residues of repeat 24 (21E-24C),  cross-linked to a 
dimer that migrated at twice the size of the original construct. 
ABP's most carboxy-terminal 65 residues are therefore criti- 
cal for dlmerization. Although it is conceivable that the hex- 
apeptide RSRPRL encoded at the carboxy terminus of the 
fusion protein might inhibit either self-association or DMA- 
mediated cross-linking, this would not negate the implica- 
tion that the structure of the 24th repeat is critical to self- 
association. 
mAbs 1 and 2 did not bind to the expressed construct of 
residues 2,282-2,647,  consistent with their observed bind- 
ing to the ~/-galactosidase  fusion protein encoded by clone 
2 containing residues  1,290-2,029  (Fig.  1).  Because these 
two mAbs bound to the 100-kD calpain fragment that begins 
at residue  1,762, the epitopes  recognized by these mAbs 
must reside between residues 1,762 and 2,029 (see Fig. 4 c). 
Discussion 
In electron micrographs, rotary shadowed molecules of ABP 
have a contour length '~160 run and appear as pairs of thread- 
like strands, linked at one end, which we have designated the 
tail (26).  The opposite ends, defined as heads, contain actin 
filament binding sites.  The region near the head is flexible 
and acquires a large variety of configurations, including the 
appearance of rolling into globular structures. The remainder 
of the strand appears more uniform in contour and includes 
straight segments that appear to rotate with respect to one 
another as if connected by two universal joint-type hinges. 
The first such hinge is •55  nm from the head; the second 
is located ~15 nm distal to the first, near where the tails join. 
Strands tend to separate from each other at an acute angle 
giving the junction and the overall configuration of the dimer 
a V shape. Rotation at the apparent hinges, and between each 
backbone repeat segment, may permit ABP to contort, al- 
lowing the actin-binding sites to attach to the same actin fila- 
ment or to link actin filaments at right angles (26).  The pri- 
mary structure of  ABP reported in this paper reveals features 
that permit a first approximation as to why it exhibits this 
morphology and how it functions as a  potent actin-cross- 
linking and actin-integral membrane protein-ligating agent. 
The Actin-binding Domain 
The orientation determined for the ABP subunit indicated 
that the actin-binding head is near its amino terminus, and 
that this region is similar to putative actin-binding domains 
of other actin filament-binding proteins. These regions have 
been identified as putative actin-binding sites by actin-fila° 
ment cosedimentation studies on proteolytic (29)  or selec- 
tively expressed fragments in several of these proteins. A re- 
cent  study,  fragmenting  the  Dictyostelium  abp-120  with 
trypsin,  showed that  a  cleavage  resulting  in  the  loss  of 
residues 89 through 115 of the Dictyostelium protein corre- 
lates with the loss of actin-binding activity (5).  Fragments 
generated by trypsin or by calpain encompassing the amino- 
terminal 90-kD or ,~840 residues of the ABP subunit bind 
actin filaments, but genetically engineered polypeptides con- 
taining residues 183-689,  e.g., beginning '~20 kD from the 
amino-terminus of ABP did not. Therefore, if the expressed 
hybrid protein achieved native conformation, it can be in- 
ferred that actin-binding by ABP requires the first 20 kD of 
amino-terminal sequence. 
The Rod and Tail Domains 
General Structure of the Rod and Tail. The rod and tail 
contain 24 repeating motifs averaging 96 residues each. The 
motifs in  turn  consist of 6-8  runs  of 6-9  residues  with 
predicted/~-sheet structure spaced '~12 residues apart inter- 
spersed with 3--4 amino acids with high turn potential. Self- 
association requires a domain in the last half  of  the last repeat 
as shown by the ability to cross-link a polypeptide including 
the last four repeats, but failure to cross-link one missing the 
last 65 residues. 
A Model for the Rod and Tail. Although any conclusions 
regarding higher order structure based on primary amino 
acid sequence must be tentative, it is possible to construct 
an  attractive  if not  exclusive model  to  explain  how  the 
96-amino acid repeats assemble in the ABP subunits. First, 
as a general principle, the series of 24 E-sheet repeats, pro- 
vides a system of building blocks to construct a long strand 
whose mechanical properties  are  determined by how the 
blocks orient with respect to one another within the subunit 
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Figure 9.  The structural  repeat of the ABP backbone•  (A) Dotplot of human ABP versus itself. The comparison shows 24 strong repeats 
in the ABP  subunit.  The repeats  begin at about  residue 275  and continue through  ABP's  carboxy terminus. The dotplot was generated 
with a window size of 20 and a stringency of 14.  Five gap regions are apparent within ABP's  carboxy third corresponding to divergence 
from the consensus sequence at the initial portion of repeat motifs 16,  18, 20, 22, and 24. The gaps indicated  by the larger arrows,  before 
repeats  16 and 24, are 20-40 residue insertions. The gap before 18 corresponds to a 9-residue deletion. (B) Alignment of 24 repeats  num- 
bered at the left. A computer-generated consensus sequence is given and the general predicted  location of turns and B-sheets are shown. 
Residues with high turn potential (G, P, N) are shown in green. Characteristic  fl-sheet zones within a motif are labelled A-H. The B-sheets 
contain runs  of alternating  hydrophilic  residues (D, E, H, K, R; shown in aqua) and hydrophobic  (F, 1, L,  V, W,  Y; shown in magenta). 
Sequence similarity between the motifs and the structural  predictions based on Fourier analysis are  strongest towards the ends of each 
motif (see also Fig.  10 B).  The insertions of 20-40 amino acids before motifs 16 and 24 (shown in blue) correlate with sites of calpain 
cleavage.  These sequence data  are available  from EMBL/GenBank/DDBJ  under  accession number 53416. 
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The first  15  sequence repeats have the greatest regularity, 
consistent with their location within  the region  where the 
strands are separated from one another, and in a fashion that 
facilitates intrachain pairing.  The sequence similarity and 
the  strength  of the  predicted  B-sheet  structure  of  these 
repeats is strongest in the first B-sheet run (A) and the third 
through eighth runs (C-H) (Fig. 9 b). Run B in each motif 
has the lowest B-sheet potential and may instead be a flexible 
linker region between functional repeat units offset from the 
sequence repeat. B-secondary structure is formed by hydro- 
gen bonding between peptide backbones of adjacent chains 
having this conformation (11). Amino acid side chains pro- 
ject perpendicular to the plane of the backbone, and since 
residues in each stretch of/3-sheet in ABP characteristically 
alternate hydrophobic and hydrophilic side chains, the resul- 
tant B-sheet zones have both hydrophilic  and hydrophobic 
faces. Our model for orienting the hydrophobic and hydro- 
philic faces therefore incorporates a functional unit offset from 
the repeat unit,  with partial disruption of B-sheet structure 
near the carboxy-terminal repeats,  freeing some of the hy- 
drophobic faces of one subunit to interact with correspond- 
ing faces from the other.  The hydrophobic faces of regions 
C-H of one repeat and region A of the next repeat might fold 
onto themselves, forming a hydrophobic core. A model with 
this construction yields a series of staggered building blocks 
shown in Figs.  4  c and  12. 
As  the  sequence  approaches the  tail,  it changes  in  two 
ways.  First,  two  intervening  amino acid  insertions  before 
repeats 16 and 24 interrupt the repeat structure to establish 
hinges, discussed in greater detail below. Second, the amino- 
terminal half of even repeats, from number 16 through 24, 
diverge from the consensus repeat. Repeat 18 is notable for 
an apparent deletion of nine amino acids and repeats 20 and 
22 each contain a cluster of positive charged residues in lieu 
of runs A and B within the repeat. The effect of each of these 
modifications may be to disrupt the alternating neighbor in- 
teraction characteristic of repeats 1 through 16 and to create 
unpaired  hydrophobic faces.  As a  result,  the hydrophobic 
faces of the repeats are able to interact with their counter- 
parts in the opposite strand, thereby producing self-associa- 
tion (as detailed in Fig.  12b). Alternatively, the large inser- 
tion at the beginning of repeat 24 and abrupt termination of 
the repeat, before the end of a functional repeat, might pre- 
vent a final intrachain hydrophobic interaction and shift it to 
interchain bonding. The last four repeats are sufficient and 
the last half of the last motif is essential for dimerization, but 
we cannot rule out some further contribution of repeats 16- 
20 to this function. The tight linkage of ABP subunits to one 
another under physiological ionic conditions and inability to 
be separated by chaotropic agents but rather only by SDS, 
is consistent with hydrophobic linkage between the subunits 
(26). Therefore, the deviation from the consensus in the car- 
boxy third of the ABP subunit may contribute to a shift from 
intrachain to interchain pairing. 
An  alternative  model,  ir.  which  all  of the  hydrophobic 
faces from each B-sheet run within a 96-amino acid repeat 
share one orientation, was proposed for Dictyostelium abp- 
120, the only other protein in which a B-turn motif structure 
similar to that in ABP has been observed (41).  This model 
predicts that each ~100-residue repeat forms a planar unit 
with both a hydrophilic and hydrophobic face. As a general 
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Figure 10. (A) Fourier transform of the ~3-structure potential along 
the ABP rod domain. This method expressed the variation of B-po- 
tential along the sequence in terms of a sum of cosine wave func- 
tions and produced a spectrum of waves. This is analogous to ex- 
pressing sound waves as a spectrum.  Peaks indicated the presence 
of strong periodicities in the ~-secondary structure potential. Anal- 
ogous to musical notes, there was both a fundamental frequency (at 
a wavelength of 96 residues) and a series of overtones.  The fun- 
damental frequency corresponded to the 96-residue repeating motif 
detected by the dotplot analysis in Fig. 9 a. The 8th and 9th over- 
tones were particularly  strong and corresponded to wavelengths of 
12 and 10.7 amino acid residues, respectively. This indicated that 
within each 96-residue motif, there was an internal fine structure 
in the B-potential that repeated about eight times. (B) Filtered trace 
of the variation of/3-potential (full lines) and turn potential (broken 
lines) along the ABP sequence. This filtered trace was produced by 
using information near the overtone peaks from the respective Fou- 
rier transforms with methods analogous to those used to filter elec- 
tron micrographs of regular biological objects (see reference 52, for 
review).  This  filtering averaged the data from all 24 of the 96- 
residue repeats and showed that the peaks in B-potential were out 
of phase with those for turns, indicating that the secondary struc- 
ture of the repeating motif was composed of a series of short runs 
of 3-structure alternating with turns. This figure shows three repre- 
sentative motifs (numbered  9,  10, and 11).  Each motif contains 
eight peaks in j3-potential which correlates with the eight zones la- 
beled A through H identified in Fig. 9 b. The peaks vary in size cor- 
relating with the strength of predicted/3-potential.  Zones D-H have 
the  strongest  predicted  ~-potential,  whereas  zone  "B"  has  the 
weakest. 
rule,  such hydrophobic faces must either pair with neigh- 
bors, pair across chains, or fold back on themselves, forming 
U-shaped structures stabilized by a hydrophobic core. Hence 
the  '~100-residue  repeat  might  be planar  or  it  might  be 
folded. If planar, each repeat could pair with a contiguous 
repeat on the same strand or might interact with a repeat on 
the  opposite  strand.  If folded,  the  functional  unit  would 
resemble a bead on a string.  The model proposed for Dic- 
tyostelium abp-120 has antiparallel dimeric structure with al- 
most complete overlap of the repeating cross-B-sheet motifs 
that lie in a coplanar orientation, allowing the hydrophobic 
faces of the repeating units from one strand to interact with 
corresponding  faces from the other monomer.  For human 
ABP, a planar orientation of seven to eight antiparallel runs 
Gorlin et al.  The Primary Structure of Human ABP  1101 Figure 11. Chemical cross-linking of hybrid proteins including truncates  of ABP's carboxy terminus  (21E-24H and 21E-24C)  expressed 
by Cos cells demonstrate that self-association requires the last 65 residues.  (,4) Cos cells were transfected with the CDM8 plasmid vector 
that included the 5' portion of plasma gelsolin cDNA, (the portion encoding its signal peptide and plasma extension, linked to ABP cDNA 
encoding ABP's carboxy terminus: motifs 21-24. The fusion protein's amino-terminal signal sequence is cleaved off  during secretion leaving 
12 residues from plasma gelsolin's amino-terminal  extension connected to the amino terminus of the ABP truncate.  These residues are 
recognized by a polyclonal anti-plasma gelsolin antibody. Two carboxy-terminal constructs were made each linking the middle of repeat 
21 (ABP residue 2,282) to the plasma gelsolin sequences. The former construct (21E-24H = residues 2,282-2,647) ended at ABP's native 
stop codon whereas the latter construct  (21E-24C, residues 2,282-2,582) deleted ABP's 65 carboxy-terminal  residues by cutting at the 
Pst I site (base •7,915  in Fig. 3) and ligating to a Pst I site in CDM8. Transcription of the latter construct was terminated by an in-frame 
stop codon encoded by CDM8 after 18 nucleotides (encoding the hexapeptide RSRPRL). (B) Demonstration that self-association requires 
an intact last repeat.  The first lane in each set of three lanes includes the uncross-linked  expressed construct  and the second and third 
lanes in each set of three lanes are after two hours of crosslinking with two concentrations of DMA, a reagent that crosslinks native ABP 
(61, 64).  Lanes 1-3 are the ABP truncate  (21E-24C)  missing the last half of the last repeat,  which on SDS-PAGE ran ~40 kD. Lanes 
4-6 show the fusion protein including ABP's native carboxy terminus (21E-24H), migrating at "°50 kD. Lanes 7-9 show plasma gelsolin 
expressed in an identical fashion in Cos cells, running at 93 kD. Only the fusion protein including ABP's native carboxy terminus (21E-24H) 
crosslinked,  resulting in a polypeptide  migrating at 105 kD (lanes 8 and 9), about twice the size of the original construct.  Neither the 
ABP construct  deleted at the carboxy terminus,  nor the native gelsolin self-associate sufficiently to allow cross-linking. 
of eight to nine amino acids with/~-sheet structure predicts 
3.0-3.5  x  2.8-3.0  ×  1.5 nm dimensions per planar unit mo- 
tif. Such an antiparallel dimer model requiring overlap of all 
24 repeating units in ABP predicts a molecule of end-to-end 
distance  considerably  shorter  than  ABP's  actual  contour 
length of 160 nm (26). 
In addition, despite a general similarity in motif structure, 
a number of differences exist between ABP and Dictyostelium 
abp-120.  Fourier analysis suggests that the H-sheet runs within 
each repeat are shorter and more numerous in the Dictyo- 
stelium  protein and  fail to  show  the  sequence  degeneracy 
found between ABP repeat motifs at the carboxy terminus. 
These differences may be sufficient to alter the mode of mo- 
tif-motif and monomer-monomer interactions. Further evi- 
dence for structural differences between the two proteins is 
the observation that ABP does not share the aberrancy of 
migration on electrophoresis in dodecyl sulfate reported for 
Dictyostelium  abp-120 (13, 41).  The open reading frame of 
Dictyostelium  abp-120 cDNA predicts a polypeptide of Mr 
92,200,  whereas the mature protein migrates with proteins 
of Mr 120,000 (explaining its name). ABP cDNA predicts a 
polypeptide subunit of 280 kD, and physical measurements 
lead to a  similar value (26).  Finally,  electron micrographs 
of Dictyostelium  abp-120 are reportedly consistent with di- 
merization by antiparallel overlap of the polypeptides along 
their contour length in contrast to all of the evidence showing 
that ABP monomers interact only at their carboxy termini (41). 
The Hinges.  Excluding the entire amino-terminal head, 
sequence insertions before repeats  16 and 24 deviate most 
noticeably from the high degree of internal sequence conser- 
vation.  The finding that ealpain, which proteolyzes on the 
basis of secondary and tertiary protein structure, cleaved the 
ABP subunits at these sites, suggests the presence of a unique 
structure at the insertions and is consistent with the hypothe- 
sis that they represent discontinuities  observed in electron 
micrographs of ABP strands. Calpain proteolysis studies of 
platelet  GPIb/IX-ABP  complexes  indicate  that  GPIb/IX 
binding takes place within the earboxy-terminal 100 kD of 
the ABP subunit,  and removal of the ultimate  10 kD abro- 
gates this binding. The GPIb/IX binding site must therefore 
locate near the insertion before motif 24. The presence of the 
second hinge at that site produced by extension of the poly- 
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Figure 12. (A) Diagram showing the proposed 
arrangement of cross-B-sheets within repeats 
forming the backbone of  the ABP molecule and 
changes that contribute  to generation of the 
self-association site at the last half of repeat 24. 
The backbone of the molecule is formed out of 
the 23 repeat units having the functional repeat 
subunit offset from the sequence repeat shown 
in Fig. 9 b. Repeats in the backbone may join 
in the following fashion: a planar hydrophobic 
face is formed by alignment of  the hydrophobic 
faces of B-sheet zones C to F. Each zone of the 
cross-B-sheet is indicated by a circle. Circles 
with dots and X's at their centers represent an- 
tiparallel B-sheets running into or out of the 
plane of the paper, respectively (i.e., cross-B- 
sheets). The hydrophobic face formed on one 
side of the planar sheet from zones C-F inter- 
acts  with  a  hydrophobic  face  presented  by 
zones G and H of the same repeat and run A of 
the next repeat. This pattern of intrachaln re- 
peat bonding establishes the backbone from 
motifs 1-23, although it is interrupted by the in- 
sertion before motif 16. The large insertion be- 
fore the terminal repeat disrupts the overlap- 
ping bonding pattern and creates an unpaired 
hydrophobic face formed by the B-sheet zones 
C-Hin motif  24. This creates a self-association 
site by allowing pairing between corresponding 
hydrophobic faces of  each 24th repeat. (B) Par- 
allel alignment of the two hydrophobic faces 
formed by B-sheet runs D to H in motif 24. In 
this diagram, the shadowed residues  indicate 
alternating residues on the hydrophobic faces 
of the motif.  Charged residues that interrupt 
the hydrophobic face are indicated by circles 
(clear circles, negatively  charged, darkened cir- 
cles,  positively charged).  Most charged resi- 
dues locate near turns. A parallel orientation of 
ABP monomers is shown as ionic interactions 
between the few charged residues neutralize ap- 
parent disruptions of the hydrophobic face. 
peptide chain away  from the backbone of repeat B-sheets 
could present a binding site to membrane glycoproteins. 
Phosphorylation  Sites.  In  view  of the  observed phos- 
phorylation of ABP in vivo and in vitro (8, 9, 59, 67), the 
primary  structure was  examined for phosphorylation site 
consensus sequences. A cAMP-dependent kinase phosphor- 
ylation was identified at residues 2,147-2,152 in motif  20 and 
a  Ca2+/calmodulin  kinase phosphorylation site at residues 
2,520-2,523  in the amino acid insertion before motif 24. 
These findings are provocative, since phosphorylation at the 
first site might affect the ability of calpaJn to hydrolyze the 
ABP subunit at the first hinge, and could explain how cAMP 
kinase-mediated phosphorylation of ABP reportedly increases 
its resistance to calpain proteolysis (9). Phosphorylation might 
neutralize the clusters of positive charges at the beginnings 
of repeats 20, allowing the subunits to come together. The 
locations of the second site suggests it may regulate the inter- 
action of ABP with membrane glycoproteins. 
ABP as a Leaf Spring: the ABP Subunit Structure 
and Actin Cross-linking 
The large extension and high radius of gyration documented 
for ABP  were proposed as  prerequisites  for the  efficient 
cross-linking of actin filaments by ABE because they permit 
the actin-binding domains in the heads of the strands to lo- 
cate and then fit firmly along the helix groove of adjacent 
actin filaments (37) or even the same filament (26). It is note- 
worthy that other proteins with similar amino-terminal se- 
quences that bundle actin filaments, namely the subunits of 
a-actinin, ~-spectrin and Dictyostelium abp-120, all form an- 
tiparallel dimers. These dimers appear as straight rods in the 
electron microscope, suggesting that although the individual 
strands might be flexible, they acquire rigidity by overlap- 
ping antiparallel pairing with their partners.  Furthermore, 
dimer overlap in the cases of a-actinin and spectrin allow for 
actin filament binding to be regulated by calcium since the 
actin-binding region on one strand is covered by an EF hand 
region belonging to the opposing strand. ABP deviates from 
this pattern in that its actin-binding sites reside at the ends 
of free strands, consistent with the observation that neither 
Ca  2+, nor phosphorylation state regulate filament binding. 
Most of ABP's backbone appears less flexible than its head, 
but because of its extended length, free rotation between the 
building blocks could contribute significantly to overall flex- 
ibility.  Finally, the hinges observed in electron micrographs 
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the molecule could swivel considerably. 
Flexibility,  though necessary,  is not sufficient to explain 
how  ABP  promotes  nearly  perpendicular  interactions  of 
cross-linked actin filaments,  because this function requires 
constraints of movement to maintain high-angle branching. 
The proposed model exhibits progression from intrachain to 
interchain hydrophobic interactions between building blocks 
constructed from/3-sheet repeats. This creates a bivalent leaf 
spring whose leaves are joined firmly at one end. In addition 
to the interchain interactions that produce self-association at 
the ultimate carboxy terminus of ABE  additional bonding 
within repeat domains 16-23 could act to stabilize the sepa- 
ration angle of the subunits by zipping the subunits together 
in this region. Interspecies differences between the sequences 
encoding  the hinges,  the  carboxy-terminal  repeats,  or re- 
gions  subjected  to posttranslational  modifications  such as 
phosphorylation, could explain the consistently greater actin 
gelation potency observed for ABP from rabbit macrophages 
(6),  amphibian oocytes  (15),  and human uterus (Egan,  S., 
and J. H. Hartwig, unpublished observations) as compared 
with ABP/filamin  from chicken gizzard  (6,  14, 42,  45). 
The large amino-terminal fragment generated by calpain 
bound to F-actin with reduced avidity compared with that of 
native ABP (Fig. 7), but the diminution in binding affinity 
was much less than would be predicted from conversion of 
a bivalent ligand to a monovalent one (46). This result is also 
consistent  with  the  proposed  leaf  spring  model.  Tension 
generated  by the  zipping  together  of subunits at the  self- 
association  region  might  functionally  reduce  the  binding 
avidity of the bivalent species for actin filament in compari- 
son with a monovalent subunit not so constrained.  An in- 
creased capacity of monomers for actin also suggests that ad- 
ditional,  low-affinity  actin-binding  sites  exist on  ABE  As 
dimers, ends of molecules are bound to different actin illa- 
ments. Filament motions would extend ABP strands, dimin- 
ishing the amount of each strand making contact with actin. 
In a relaxed state (monomer), more of the ABP strand could 
contact  the  actin  filament,  stabilizing  the  ABP-filament 
bond. ABP may therefore bind actin initially using its widely 
separated  amino-terminal  binding  sites.  Binding  of addi- 
tional actin monomers along the filament could help stabilize 
the branched configuration. 
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